Teal, P., Hacke, W., & Hennerici, M. G. (2009). A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: Modified Randomized Exposure Controlled Trial (mRECT). Stroke, 40(11), . https://doi.org/10.1161/STROKEAHA.109.551382
Chicago-Zitierstil (17. Ausg.)Teal, Philip, Werner Hacke, und Michael G. Hennerici. "A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetic/pharmacodynamic Effects of a Targeted Exposure of Intravenous Repinotan in Patients with Acute Ischemic Stroke: Modified Randomized Exposure Controlled Trial (mRECT)." Stroke 40, no. 11 (2009). https://doi.org/10.1161/STROKEAHA.109.551382.
MLA-Zitierstil (9. Ausg.)Teal, Philip, et al. "A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetic/pharmacodynamic Effects of a Targeted Exposure of Intravenous Repinotan in Patients with Acute Ischemic Stroke: Modified Randomized Exposure Controlled Trial (mRECT)." Stroke, vol. 40, no. 11, 2009, https://doi.org/10.1161/STROKEAHA.109.551382.